Loading...
Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report
BACKGROUND: Targeted therapy with tyrosine kinase inhibitors has been shown to reduce tumor volumes and prolong the survival of patients with metastatic renal cell carcinoma. Tyrosine kinase inhibitors, particularly sunitinib, have recently been used in neoadjuvant and presurgical settings. Axitinib...
Na minha lista:
| Udgivet i: | BMC Res Notes |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4222084/ https://ncbi.nlm.nih.gov/pubmed/24267160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-6-484 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|